Kuros Biosciences AG Cash Flow Conversion Efficiency

Latest as of June 2026: -0.031x

Kuros Biosciences AG cash flow conversion efficiency. Based on the latest financial reports, Kuros Biosciences AG (KURN) has a cash flow conversion efficiency ratio of -0.031x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF-2.24 Million ≈ $-2.83 Million USD) by net assets (CHF72.00 Million ≈ $91.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Kuros Biosciences AG (2004–2025)

Cash flow conversion efficiency of Kuros Biosciences AG from 2004 to 2025. This chart illustrates how Kuros Biosciences AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Kuros Biosciences AG (KURN) share price today for real-time trading data and today's change.

Kuros Biosciences AG Cash Flow Conversion Ratio Explained

Kuros Biosciences AG cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Kuros Biosciences AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kuros Biosciences AG ranked by their cash flow conversion efficiency. Also see KURN market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Bergman & Beving AB (publ) ST:BERG-B	0.065x
Riley Exploration Permian Inc NYSE MKT:REPX	0.085x
Kingsgate Consolidated Ltd AU:KCN	0.153x
Ridgepost Capital, Inc NYSE:RPC	0.042x
Shenzhen Chengtian Weiye Technology Co Ltd SHE:300689	0.008x
Quantum Corporation NASDAQ:QMCO	-0.034x
MAS Real Estate Inc JSE:MSP	0.001x
Shanghai Join Buy Co Ltd SHG:600838	0.003x

Annual Cash Flow Conversion Efficiency for Kuros Biosciences AG (2004–2025)

The table below shows the annual cash flow conversion efficiency of Kuros Biosciences AG from 2004 to 2025. Review Kuros Biosciences AG free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CHF66.93 Million ≈ $84.62 Million	CHF-377.87K ≈ $-477.73K	-0.006x	-110.56%
2024-12-31	CHF58.75 Million ≈ $74.27 Million	CHF3.14 Million ≈ $3.97 Million	0.053x	+134.27%
2023-12-31	CHF56.71 Million ≈ $71.70 Million	CHF-8.84 Million ≈ $-11.18 Million	-0.156x	-46.14%
2022-12-31	CHF68.86 Million ≈ $87.06 Million	CHF-7.35 Million ≈ $-9.29 Million	-0.107x	-50.63%
2021-12-31	CHF76.98 Million ≈ $97.32 Million	CHF-5.45 Million ≈ $-6.89 Million	-0.071x	+35.13%
2020-12-31	CHF84.60 Million ≈ $106.96 Million	CHF-9.24 Million ≈ $-11.68 Million	-0.109x	+21.63%
2019-12-31	CHF77.86 Million ≈ $98.43 Million	CHF-10.85 Million ≈ $-13.72 Million	-0.139x	+16.98%
2018-12-31	CHF76.48 Million ≈ $96.70 Million	CHF-12.84 Million ≈ $-16.23 Million	-0.168x	-14.97%
2017-12-31	CHF73.14 Million ≈ $92.47 Million	CHF-10.68 Million ≈ $-13.50 Million	-0.146x	+37.09%
2016-12-31	CHF38.32 Million ≈ $48.45 Million	CHF-8.89 Million ≈ $-11.24 Million	-0.232x	+93.82%
2015-12-31	CHF669.00K ≈ $845.80K	CHF-2.51 Million ≈ $-3.18 Million	-3.758x	-514.73%
2014-12-31	CHF-26.22 Million ≈ $-33.15 Million	CHF-23.76 Million ≈ $-30.04 Million	0.906x	+119.99%
2013-12-31	CHF4.23 Million ≈ $5.35 Million	CHF-19.17 Million ≈ $-24.24 Million	-4.532x	-293.95%
2012-12-31	CHF10.03 Million ≈ $12.68 Million	CHF-11.54 Million ≈ $-14.59 Million	-1.150x	-252.56%
2011-12-31	CHF-11.68 Million ≈ $-14.77 Million	CHF-8.81 Million ≈ $-11.13 Million	0.754x	+206.14%
2010-12-31	CHF6.59 Million ≈ $8.34 Million	CHF-4.68 Million ≈ $-5.92 Million	-0.710x	+61.61%
2009-12-31	CHF8.24 Million ≈ $10.42 Million	CHF-15.25 Million ≈ $-19.28 Million	-1.850x	-111.33%
2008-12-31	CHF31.86 Million ≈ $40.28 Million	CHF-27.89 Million ≈ $-35.27 Million	-0.876x	-983.67%
2007-12-31	CHF54.43 Million ≈ $68.82 Million	CHF-4.40 Million ≈ $-5.56 Million	-0.081x	+87.07%
2006-12-31	CHF45.90 Million ≈ $58.03 Million	CHF-28.67 Million ≈ $-36.25 Million	-0.625x	-70.75%
2005-12-31	CHF74.01 Million ≈ $93.57 Million	CHF-27.08 Million ≈ $-34.23 Million	-0.366x	-29.32%
2004-12-31	CHF80.17 Million ≈ $101.36 Million	CHF-22.68 Million ≈ $-28.68 Million	-0.283x	--

About Kuros Biosciences AG

SW:KURN Switzerland Medical Devices

Market Cap

$1.04 Billion

CHF818.86 Million CHF

Market Cap Rank

#10047 Global

#130 in Switzerland

Share Price

CHF20.64

Change (1 day)

-0.96%

52-Week Range

CHF16.46 - CHF32.00

All Time High

CHF36.96